Monoclonal Antibodies Against Bladder Cancer Cells
Author Information
Author(s): H. Ben-Aissa, S. Paulie, H. Koho, P. Biberfeld, Y. Hansson, M.L. Lundblad, H. Gustafson, I. Jonsdottir, P. Perlmann
Primary Institution: Department of Immunology, The Wenner Gren Institute, University of Stockholm
Hypothesis
Can monoclonal antibodies be developed to specifically target antigens associated with transitional cell carcinoma of the human urinary bladder?
Conclusion
The study identified two monoclonal antibodies that can distinguish between malignant and normal bladder cells, indicating potential for diagnostic and therapeutic applications.
Supporting Evidence
- Antibody P7A5-4 could discriminate between malignant and normal bladder cells.
- Antibody SK4H-12 showed strong reactivity with bladder carcinoma cells.
- Both antibodies were tested against a panel of human cells and tissues.
Takeaway
Scientists created special antibodies that can tell the difference between sick and healthy bladder cells, which could help doctors find and treat bladder cancer better.
Methodology
Mice were immunized with bladder cancer cells, and hybridomas were produced and screened for antibody production using ELISA and immunofluorescence.
Limitations
The study's findings may not be entirely specific to bladder cancer as some antibodies showed reactivity with non-TCC cells.
Participant Demographics
Balb/c mice were used for immunization.
Want to read the original?
Access the complete publication on the publisher's website